Last updated: July 15, 2026  ·  ← Back to Stock Fact Sheets

Oracle Corporation (ORCL) — Company Overview

Oracle Corporation (NYSE: ORCL) is one of the world’s largest enterprise technology companies, headquartered in Austin, Texas. Founded in 1977 by Larry Ellison, Bob Miner, and Ed Oates, Oracle has spent five decades building the dominant database technology used by the vast majority of the world’s largest companies, governments, and institutions. CEO Safra Catz has led the company’s financial strategy since 2014, while founder Larry Ellison — as Executive Chairman and Chief Technology Officer — continues to drive the product and AI vision. The company is in the midst of its most significant transformation: from a legacy on-premise database and software vendor into one of the world’s fastest-growing cloud infrastructure providers.

Q4 & FY2026 Earnings: Record Everything

Oracle reported record Q4 and full fiscal year 2026 results on June 10, 2026. Q4 total revenues were $19.2 billion (+21% YoY). Cloud revenues hit $9.9 billion (+47%), crossing 52% of total revenue for the first time. Cloud Infrastructure (IaaS) grew 93% to $5.8 billion — faster than AWS, Azure, or Google Cloud in the same period. The Remaining Performance Obligations backlog surged $85 billion sequentially to $638 billion (+363% YoY), driven by large-scale AI contracts. FY2026 total revenue was $67.4 billion (+17%), operating cash flow hit a record $32 billion (+54%), and non-GAAP EPS grew 27% to $7.63. For the full earnings breakdown: Oracle Q4 & FY2026 Earnings: Record $19.2B Quarter, IaaS Grows 93%, RPO Hits $638B.

The AI Infrastructure Story

Oracle’s $638 billion RPO is the most important number in the company’s history. Most of the increase in Q3 and Q4 came from large-scale AI contracts where customers either prepay Oracle for GPU purchasing or supply their own GPUs to Oracle’s infrastructure. These prepaid and customer-supplied hardware commitments now total $75 billion, dramatically reducing the capital Oracle must raise to build out its AI data centers. Oracle is building data centers using clean energy from natural gas fuel cells, and its high-performance networking, advanced security, and autonomous software stack have made OCI the world’s fastest-growing provider of cloud data centers by percentage growth. The Oracle Multicloud AI Database grew 404% in Q4 — the fastest of any Oracle business in history — as enterprises adopt Oracle’s data layer across AWS, Azure, and Google Cloud simultaneously.

July 2026 Selloff: What Changed

Despite the record Q4 print, Oracle shares fell 28–35% over a roughly one-month stretch in the first half of July 2026, touching a fresh 52-week low near $132. The catalyst was a shift in narrative rather than new operating data: S&P Global flagged Oracle’s growing revenue concentration tied to OpenAI and projected a roughly $42 billion free-cash-flow deficit for fiscal 2027 as the company continues borrowing heavily to fund its AI data center buildout. Oracle Vice Chairman Jeffrey Henley’s sale of large stock blocks in the $156–$165 range added to the cautious tone. Even so, sell-side coverage has remained overwhelmingly positive — 37 Buy ratings against just 1 Sell, with an average price target near $251.85 — and Oracle remains the only profitable name among the major AI-cloud infrastructure stocks, a distinction that has drawn renewed attention as investors sort winners from losers in the space. For a broader look at this pullback alongside similar moves in Intel and CoreWeave, see our AI stock selloff analysis.

FY2027 Guidance and Oracle Health

Oracle confirmed $90 billion in FY2027 total revenue guidance and raised non-GAAP EPS guidance to $8.05. Q1 FY2027 cloud revenue is expected to grow 57–63% in constant currency — an acceleration from Q4’s 46%. Oracle Health, the company’s healthcare IT division built on the Cerner acquisition, is expected to accelerate to double-digit growth in FY2027 with a new AI-native Cerner patient care management system. Larry Ellison described AI as being poised to “completely revolutionize healthcare,” including AI molecular drug design and a new clinical trial review system.

Related Coverage on FactSheets.com

• Oracle Q4 & FY2026 Earnings: Record $19.2B Quarter, IaaS Grows 93%, RPO Hits $638B
• Oracle hires new CFO with $950K salary as thousands face layoffs
• MSFT — Microsoft Stock Fact Sheet
• GOOGL — Alphabet Stock Fact Sheet
• AMZN — Amazon Stock Fact Sheet
• CRWV — CoreWeave Stock Fact Sheet
• NVIDIA Q1 FY2027 Earnings: $81.6B Revenue, $91B Q2 Guide
• All Stock Fact Sheets

For informational purposes only. Not investment advice. Data as of July 15, 2026.